Words Matter: Different Definitions of “Commercially Reasonable Efforts” Lead to Different Results in Drug-Development Earnout Disputes

October 1, 2024

In Case of First Impression, Court of Chancery Awards Expenditures Incurred in Third-Party Litigation as Breach of Contract Damages

August 22, 2024

Director Wins In Claim of Improper Removal – But Still Loses

July 8, 2024

Controller’s Ability to Appoint and Remove Directors at Will Insufficient to Establish Demand Futility

April 29, 2024

Securities Litigation Against Life Sciences Companies: 2023

April 12, 2024

Voting Commitments Matter and Will Be Enforced: Delaware Supreme Court Affirms Chancery Decision Holding Activist Stockholders to Their Bargain

March 21, 2024

For Delaware LLCs, Contractual Freedom Overrides Equitable Defenses

September 20, 2023

Securities Litigation Against Life Sciences Companies: Eleven Takeaways from 2022

May 17, 2023